HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients
Table 1
Demographic, virological and clinical characteristics of the on-treatment population.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Demographic, virological and clinical characteristics of the on-treatment population.